Background Blood derived medicines (BDM) need, as a result of their status, strict and obligatory traceability at each step of their circuit. Administration traceability for BDM has to be kept for 40 years at the pharmacy. However, care teams do not always spontaneously send traceability to the pharmacy, which makes this aspect of the regulatory obligation difficult.

Purpose We wished to evaluate the pharmaceutical team’s interventions in recovering BDM traceability by analysing claims made to paramedical teams.

Material and methods We prospectively collected traceability requests to hospital wards over a -months period (March 2016 to September 2016).

Results Over the study period, 3361 BDM were distributed. Products were always delivered to the hospital wards with a specific traceability label, traceability sheets and a leaf reminding them to send back the traceability sheet with the specific label to the pharmacy after every BDM administration. Despite this, 123 claims were made to return the traceability sheet for 367 products, more than 10% of distributions. In 84% of cases, a request made 8 days after distribution on average, by mail or phone call, was enough to get the traceability back. In 11% of cases a second demand was necessary, done on average 13 days after distribution. In 3% of cases a third claim was made on average 24 days after distribution. Lastly, in 3% of cases a fourth request was made on average 35 days after distribution. After at least one demand, we obtained traceability 14 days on average after the distribution. Hence implementation of regulatory administration’s traceability is still difficult for some care teams and needs the pharmacy’s intervention.

Conclusion This work highlights the importance of the pharmacy’s intervention to obtain an exhaustive collection of administration traceability of BDM. Training actions for paramedical teams about the importance of traceability and the circuit of BDM are being set up via competency workshops. These workshops are currently created by pharmaceutical and paramedical teams jointly.

No conflict of interest